Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We assessed diabetes risk associated with zinc transporter-8 antibodies (ZnT8A), islet cell antibodies (ICA), and HLA type and age in relatives of people with type 1 diabetes with the standard biochemical autoantibodies (BAA) to insulin (IAA), GAD65 (GAD65A), and/or insulinoma-associated protein 2 antigen (IA-2A). RESEARCH DESIGN AND METHODS: For this analysis, 2,256 relatives positive for at least one BAA, of whom 142 developed diabetes, were tested for ZnT8A, ICA, and HLA genotype followed by biannual oral glucose tolerance tests. ZnT8A were also tested in 911 randomly chosen antibody-negative relatives. RESULTS: ZnT8A were associated with the other BAA (548 of 2,256 [24.3%] BAA+ vs. 8 of 911 [0.8%] BAA−, P < 0.001) and BAA number (177 of 1,683 [10.5%] single-, 221 of 384 [57.6%] double-, and 150 of 189 [79.4%] triple-BAA positivity, P < 0.001). The 4-year diabetes risk was higher in single BAA+ relatives with ZnT8A than ZnT8A− relatives (31 vs. 7%, P < 0.001). In multivariable analysis, age ≤20 years (hazard ratio 2.13, P = 0.03), IA-2A (2.15, P = 0.005), IAA (1.73, P = 0.01), ICA (2.37, P = 0.002), and ZnT8A (1.87, P = 0.03) independently predicted diabetes, whereas HLA type (high and moderate vs. low risk) and GAD65A did not (P = 0.81 and 0.86, respectively). CONCLUSIONS: In relatives with one standard BAA, ZnT8A identified a subset at higher diabetes risk. ZnT8A predicted diabetes independently of ICA, the standard BAA, age, and HLA type. ZnT8A should be included in type 1 diabetes prediction and prevention studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“and could explain the added benefit of ICA testing within TrialNet [ 3 ].”
From Islet autoantibody profiles associated with higher diabetes risk in Lithuanian compared with English schoolchildren (2020) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154 · cited 1×
“Finally, we did not add metabolic predictors, including abnormal oral glucose tolerance (2), the Diabetes Prevention Trial Risk Score (20), insulin sensitivity (21), or A1C levels (22), to the Cox analyses because the number of diabetic case subjects (n = 94) was insufficient relative to the number of independent vari…”
BackgroundDiagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705894104 · Cited by 1,014
Self-citationEffects of insulin in relatives of patients with type 1 diabetes mellitus
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012350 · Cited by 836
Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes
The Diabetes Prevention Trial-Type 1 Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1068 · Cited by 668
Gale, E. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15786-3 · Cited by 534
Verge, C. F., Stenger, D., Bonifacio, E., Colman, P. G., Pilcher, C., Bingley, P. J., & Eisenbarth, G. S. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1857 · Cited by 420
Self-citationDietary intervention in infancy and later signs of beta-cell autoimmunity
Knip, M., Virtanen, S. M., Seppä, K., Ilonen, J., Savilahti, E., Vaarala, O., Reunanen, A., Teramo, K., Hämäläinen, A.-M., Paronen, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1004809 · Cited by 281
Clinical Applications of Diabetes Antibody Testing
Bingley, P. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1365 · Cited by 278
Self-citationOrban, T., Sosenko, J. M., Cuthbertson, D., Krischer, J. P., Skyler, J. S., Jackson, R., Yu, L., Palmer, J. P., Schatz, D., Eisenbarth, G., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0934 · Cited by 260
Self-citation
Cited by
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312
Self-citationEarly prediction of autoimmune (type 1) diabetes.
Regnell, S. E., & Lernmark, Å. (2017) · Diabetologia · doi:10.1007/s00125-017-4308-1 · Cited by 195
Campbell‐Thompson, M., Wasserfall, C. H., Montgomery, E. L., Atkinson, M. A., & Kaddis, J. S. (2012) · JAMA · doi:10.1001/jama.2012.15008 · Cited by 147
Jacobsen, L. M., Bocchino, L., Evans-Molina, C., DiMeglio, L., Goland, R., Wilson, D. M., Atkinson, M. A., Aye, T., Russell, W. E., Wentworth, J. M., et al. (2020) · Diabetologia · doi:10.1007/s00125-019-05047-w · Cited by 133
“Zinc transporter 8 autoantibodies (ZnT8A) [10] were assessed (by radioimmunoassay) if any of the three autoantibodies initially tested were positive at screening.”
BackgroundSelf-citationSosenko, J. M., Skyler, J. S., Palmer, J. P., Krischer, J. P., Yu, L., Mahon, J., Beam, C. A., Boulware, D. C., Rafkin, L., Schatz, D., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0425 · Cited by 123
“) Findings from a recent report (8) suggest that risk misclassification could occur if autoantibody number alone is relied on for prediction without regard for the pattern of positivity and autoantibody levels.”
BackgroundMethodSelf-citationΒ cell dysfunction exists more than 5 years before type 1 diabetes diagnosis
Evans-Molina, C., Sims, E. K., DiMeglio, L. A., Ismail, H. M., Steck, A. K., Palmer, J. P., Krischer, J. P., Geyer, S., Xu, P., Sosenko, J. M., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120877 · Cited by 116
“ZnT8 was measured in a limited group of PTP participants beginning in 2004 (27), and measurement of ZnT8 for the entire PTP cohort began in 2012.”
Self-citationClassification and Diagnosis of Diabetes
GENUTH, S. M., Palmer, J. P., & Nathan, D. M. (2018) · Cited by 112
Vehik, K., Bonifacio, E., Lernmark, Å., Yu, L., Williams, A., Schatz, D., Rewers, M., She, J.-X., Toppari, J., Hagopian, W., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2547 · Cited by 87
Self-citationGubitosi-Klug, R. A., Braffett, B. H., Hitt, S., Arends, V., Uschner, D., Jones, K., Diminick, L., Karger, A. B., Paterson, A. D., Roshandel, D., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143011 · Cited by 86
Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review
Watkins, R. A., Evans‐Molina, C., Blum, J. S., & DiMeglio, L. A. (2014) · Translational research · doi:10.1016/j.trsl.2014.02.004 · Cited by 101
Zampetti, S., Capizzi, M., Spoletini, M., Campagna, G., Leto, G., Cipolloni, L., Tiberti, C., Bosi, E., Falorni, A., Buzzetti, R., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2037 · Cited by 82
Self-citationAdvances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count
So, M., Speake, C., Steck, A. K., Lundgren, M., Colman, P. G., Palmer, J. P., Herold, K. C., & Greenbaum, C. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab013 · Cited by 80
Self-citationthe Type 1 Diabetes TrialNet Study Group, Bingley, P. J., Boulware, D. C., & Krischer, J. P. (2016) · Diabetologia · doi:10.1007/s00125-015-3830-2 · Cited by 70
Self-citationPugliese, A., Boulware, D., Yu, L., Babu, S., Steck, A. K., Becker, D., Rodriguez, H., DiMeglio, L., Evans-Molina, C., Harrison, L. C., et al. (2016) · Diabetes · doi:10.2337/db15-1105 · Cited by 68
Self-citationGorus, F., Balti, E. V., Messaaoui, A., Demeester, S., Dalem, A. V., Costa, O. R., Dorchy, H., Mathieu, C., Gaal, L. V., Keymeulen, B., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2228 · Cited by 68
Miao, D., Steck, A. K., Zhang, L., Guyer, K. M., Jiang, L., Armstrong, T., Muller, S. M., Krischer, J., Rewers, M., Yu, L., et al. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0186 · Cited by 64
Self-citationBosi, E., Boulware, D. C., Becker, D. J., Buckner, J. H., Geyer, S. M., Gottlieb, P. A., Henderson, C., Kinderman, A., Sosenko, J. M., Steck, A. K., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00569 · Cited by 68
Self-citationSosenko, J. M., Skyler, J. S., Mahon, J., Krischer, J. P., Greenbaum, C. J., Rafkin, L. E., Beam, C. A., Boulware, D. C., Matheson, D., Cuthbertson, D., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2359 · Cited by 60
Self-citationCharacteristics of maturity onset diabetes of the young in a large diabetes center
Chambers, C., Fouts, A., Dong, F., Colclough, K., Wang, Z., Batish, S. D., Jaremko, M., Ellard, S., Hattersley, A. T., Klingensmith, G., et al. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12289 · Cited by 59
Birth and coming of age of islet autoantibodies
Bonifacio, E. E., & Achenbach, P. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13360 · Cited by 66
for the Type 1 Diabetes TrialNet Study Group, Meah, F. A., DiMeglio, L. A., Greenbaum, C. J., Blum, J. S., Sosenko, J. M., Pugliese, A., Geyer, S. M., Xu, P., & Evans‐Molina, C. (2016) · Diabetologia · doi:10.1007/s00125-016-3924-5 · Cited by 58
Self-citationFelton, J. L., REDONDO, M. J., Oram, R. A., Speake, C., Long, S. A., Önengüt-Gümüşcü, S., Rich, S. S., Monaco, G. S. F., Harris-Kawano, A., Perez, D., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00478-y · Cited by 72
Zhao, Z., Miao, D., Michels, A. W., Steck, A. K., Dong, F., Rewers, M., & Yu, L. (2016) · Journal of Immunological Methods · doi:10.1016/j.jim.2016.01.011 · Cited by 52
Self-citationWasserfall, C., Montgomery, E., Yu, L., Michels, A., Gianani, R., Pugliese, A., Nierras, C., Kaddis, J. S., Schatz, D. A., Bonifacio, E., et al. (2016) · Clinical and Experimental Immunology · doi:10.1111/cei.12797 · Cited by 48
Self-citationGreenbaum, C. J., Speake, C., Krischer, J., Buckner, J., Gottlieb, P. A., Schatz, D. A., Herold, K. C., & Atkinson, M. A. (2018) · Diabetes · doi:10.2337/db18-0065 · Cited by 46
Self-citationCortez, F. D. J., Gebhart, D., Robinson, P. V., Seftel, D., Pourmandi, N., Owyoung, J., Bertozzi, C. R., Wilson, D. M., Maahs, D. M., Buckingham, B. A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242049 · Cited by 50
Self-citationAndersson, C., Kolmodin, M., Ivarsson, S.-A., Carlsson, A., Forsander, G., Lindblad, B., Ludvigsson, J., Kockum, I., Marcus, C., Samuelsson, U., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12093 · Cited by 44
Predictors of slow progression to diabetes in children with multiple islet autoantibodies
Steck, A. K., Dong, F., Waugh, K., Frohnert, B. I., Yu, L., Norris, J. M., & Rewers, M. J. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.05.010 · Cited by 40
Self-citationAutoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals
So, M., O’Rourke, C., Bahnson, H. T., Greenbaum, C. J., & Speake, C. (2020) · Diabetes Care · doi:10.2337/dc19-1731 · Cited by 44
Self-citationLiu, Y., Rafkin, L. E., Matheson, D., Henderson, C., Boulware, D. C., Besser, R. E. J., Ferrara, C., Yu, L., Steck, A. K., Bingley, P. J., et al. (2017) · Diabetic Medicine · doi:10.1111/dme.13338 · Cited by 39
Self-citationWhat has zinc transporter 8 autoimmunity taught us about type 1 diabetes?
Williams, C. L., & Long, A. E. (2019) · Diabetologia · doi:10.1007/s00125-019-04975-x · Cited by 39
Redondo, M. J., Muniz, J., Rodriguez, L. M., Iyer, D., Vaziri-Sani, F., Haymond, M. W., Hampe, C. S., Metzker, M. L., Grant, S. F. A., & Balasubramanyam, A. (2014) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2013-000008 · Cited by 34
Characterising the age-dependent effects of risk factors on type 1 diabetes progression
So, M., O’Rourke, C., Ylescupidez, A., Bahnson, H. T., Steck, A. K., Wentworth, J. M., Bruggeman, B., Lord, S. M., Greenbaum, C. J., & Speake, C. (2022) · Diabetologia · doi:10.1007/s00125-021-05647-5 · Cited by 38
Self-citationThe Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults
Ferrara, C. T., Geyer, S. M., Evans-Molina, C., Libman, I. M., Becker, D. J., Wentworth, J. M., Moran, A., Gitelman, S. E., Redondo, M. J., & Type 1 Diabetes TrialNet Study Group (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01490 · Cited by 33
Massa, O., Alessio, M., Russo, L., Nardo, G., Bonetto, V., Bertuzzi, F., Paladini, A., Iafusco, D., Patera, P. I., Federici, G., et al. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.02.030 · Cited by 37
Waugh, K., Snell‐Bergeon, J. K., Michels, A. W., Dong, F., Steck, A. K., Frohnert, B. I., Norris, J. M., & Rewers, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174840 · Cited by 33
GAD autoantibody affinity in schoolchildren from the general population
Bender, C., Schlosser, M., Christen, U., Ziegler, A. G., & Achenbach, P. (2014) · Diabetologia · doi:10.1007/s00125-014-3294-9 · Cited by 33
Leichter, S. B., Felton, J. L., Rasmussen, C. G., Rizzuto, P., Bellini, N. J., Ebekozien, O. A., & Schulman‐Rosenbaum, R. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf194 · Cited by 33
Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes Mellitus
Yi, B., Huang, G., & Zhou, Z. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.163389 · Cited by 31
Mbunwe, E., der Auwera, B. J. R. V., Vermeulen, I., Demeester, S., Dalem, A. V., Balti, E. V., Aken, S. V., Derdelinckx, L., Dorchy, H., Schepper, J. D., et al. (2013) · Diabetes · doi:10.2337/db12-0747 · Cited by 34
Self-citationSpeake, C., Habib, T., Lambert, K., Hundhausen, C., Lord, S. M., Dufort, M. J., Skinner, S. O., Hu, A. K., Kinsman, M., Jones, B. E., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.159436 · Cited by 30
Self-citationKahkoska, A. R., & Dabelea, D. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.007 · Cited by 38
Galderisi, A., Moran, A., Evans‐Molina, C., Martino, M., Santoro, N., Caprio, S., & Cobelli, C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab344 · Cited by 28
Antigen-specific immunotherapies in type 1 diabetes
Zhang, X., Dong, Y., Liu, D., Yang, L., Xu, J., & Wang, Q. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.127040 · Cited by 26
IA-2 autoantibody affinity in children at risk for type 1 diabetes
Krause, S., Chmiel, R., Bonifacio, E. E., Scholz, M., Powell, M. J., Furmaniak, J., Smith, B. R., Ziegler, A., & Achenbach, P. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.09.010 · Cited by 27
Bingley, P. J., Rafkin, L. E., Matheson, D., Steck, A. K., Yu, L., Henderson, C., Beam, C. A., Boulware, D. C., & the TrialNet Study Group (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0133 · Cited by 23
Self-citationIslet autoantibody positivity in overweight and obese adults with type 2 diabetes
Pilla, S. J., Balasubramanyam, A., Knowler, W. C., Lazo, M., Nathan, D. M., Pi‐Sunyer, X., Clark, J. M., Maruthur, N. M., & The Look AHEAD Research Group (2018) · Autoimmunity · doi:10.1080/08916934.2018.1547711 · Cited by 27
Evans‐Molina, C., Dor, Y., Lernmark, Å., Mathieu, C., Millman, J. R., Mirmira, R. G., Pociot, F., REDONDO, M. J., Rich, S. S., Richardson, S. J., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06462-y · Cited by 35
Compromised central tolerance of ICA69 induces multiple organ autoimmunity
Fan, Y., Gualtierotti, G., Tajima, A., Grupillo, M., Coppola, A., He, J., Bertera, S., Owens, G. P., Pietropaolo, M., Rudert, W. A., et al. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.07.001 · Cited by 23
A subclass of serum anti-ZnT8 antibodies directed to the surface of live pancreatic β-cells
Merriman, C., Huang, Q., Gu, W., Yu, L., & Fu, D. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000195 · Cited by 25
Self-citationStrollo, R., Vinci, C., Napoli, N., Fioriti, E., Maddaloni, E., Åkerman, L., Casas, R., Pozzilli, P., Ludvigsson, J., & Nissim, A. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3132 · Cited by 22
Jia, X., He, L., Miao, D., Waugh, K., Rasmussen, C. G., Dong, F., Steck, A. K., Rewers, M., & Yu, L. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab575 · Cited by 25
Self-citationNon-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies
Maziarz, M., Hagopian, W., Palmer, J. P., Sanjeevi, C. B., Kockum, I. S., Breslow, N. E., Lernmark, Å., Graham, J., MacNeney, B., Arnqvist, H. J., et al. (2015) · Genes and Immunity · doi:10.1038/gene.2015.43 · Cited by 23
Khan, W. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.68834 · Cited by 24
Zinc transporter 8 autoantibodies: what is their clinical relevance in gestational diabetes?
Rudland, V. L., Pech, C., Harding, A., Tan, K. H., Lee, K., Molyneaux, L. M., Yue, D. K., Wong, J., & Ross, G. P. (2014) · Diabetic Medicine · doi:10.1111/dme.12629 · Cited by 18
Williams, C. L., Marzinotto, I., Brigatti, C., Gillespie, K. M., The BOX Study Group, Wilson, I. S., Aitken, R. J., Megson, C., Ballav, C., Dutta, A. K., et al. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad139 · Cited by 20
Andersson, C., Carlsson, A., Cilio, C., Cedervall, E., Ivarsson, S.-A., Jónsdóttir, B., Jönsson, B., Larsson, K., Neiderud, J., Lernmark, Å., et al. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12023 · Cited by 18
Self-citationEvans‐Molina, C., Dor, Y., Lernmark, Å., Mathieu, C., Millman, J. R., Mirmira, R. G., Pociot, F., REDONDO, M. J., Rich, S. S., Richardson, S. J., et al. (2025) · Diabetes Care · doi:10.2337/dci25-0013 · Cited by 24
Loss of Znt8 function in diabetes mellitus: risk or benefit?
Barragán-Álvarez, C. P., Padilla‐Camberos, E., Díaz, N. F., Cota-Coronado, A., Hernández-Jiménez, C., Bravo‐Reyna, C., & Diaz-Martinez, N. E. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04114-4 · Cited by 18
Ling, Q., Lü, J., Li, J., Xu, Q., Zhu, D., & Bi, Y. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.09.012 · Cited by 19
Erlich, H. A., Valdes, A. M., & Noble, J. A. (2013) · Diabetes · doi:10.2337/db12-1593 · Cited by 13
Galderisi, A., Evans‐Molina, C., Martino, M., Caprio, S., Cobelli, C., & Moran, A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac740 · Cited by 13
Fichna, M., Rogowicz‐Frontczak, A., Żurawek, M., Fichna, P., Gryczyńska, M., Zozulińska‐Ziółkiewicz, D., & Ruchała, M. (2016) · Endocrine · doi:10.1007/s12020-016-0916-7 · Cited by 15
Pilla, S. J., Maruthur, N. M., Schweitzer, M., Magnuson, T. H., Potter, J. J., Clark, J. M., & Lee, C. J. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2804-5 · Cited by 15
Speake, C., Bahnson, H. T., Wesley, J. D., Perdue, N., Friedrich, D. A., Pham, M. N., Lanxon-Cookson, E. C., Kwok, W. W., Hansen, B. S., von Herrath, M., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02023 · Cited by 15
Self-citationPatel, T., Ayub, A., Bone, J. N., Hadjiyannakis, S., Henderson, M., Nour, M. A., Pinto, T. E., Wicklow, B. A., Hamilton, J. K., Sellers, E. A. C., et al. (2023) · Pediatric Diabetes · doi:10.1155/2023/5511049 · Cited by 16
Antigen-specific T cell responses in autoimmune diabetes
Dwyer, A. J., Shaheen, Z. R., & Fife, B. T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1440045 · Cited by 17
REDONDO, M. J., Cuthbertson, D. D., Steck, A. K., Herold, K. C., Oram, R. A., Atkinson, M. A., Brusko, T. M., Parikh, H. M., Krischer, J. P., Önengüt-Gümüşcü, S., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06338-7 · Cited by 14
Self-citationFelton, J. L., Cuthbertson, D. D., WARNOCK, M. V., Lohano, K., Meah, F. A., Wentworth, J. M., Sosenko, J. M., Evans‐Molina, C., & for the Type 1 Diabetes TrialNet Study Group (2021) · Diabetologia · doi:10.1007/s00125-021-05573-6 · Cited by 10
Self-citationIndex60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 Diabetes
Jacobsen, L. M., Bundy, B. N., Ismail, H. M., Clements, M. A., WARNOCK, M. V., Geyer, S. M., Schatz, D., & Sosenko, J. M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac440 · Cited by 11
Self-citationAraújo, D. B., Skärstrand, H., Barone, B., Dantas, J. R., Kupfer, R., Zajdenverg, L., Milech, A., Vaziri‐Sani, F., de Oliveira, J. E. P., & Rodacki, M. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003088 · Cited by 9
Precision Diagnostics: Using Islet Autoantibodies to Characterize Heterogeneity in Type 1 DiabetesPreprint
Felton, J. L., REDONDO, M. J., Oram, R. A., Speake, C., Long, S. A., Önengüt-Gümüşcü, S., Rich, S. S., Monaco, G. S. F., Harris-Kawano, A., Perez, D., et al. (2023) · medRxiv · doi:10.1101/2023.04.18.23288756 · Cited by 8
Prevalence of Islet Autoantibodies in Adults Without Diabetes
PAULEY, M. E., Simmons, K. M., Dong, F., Yu, L., Steck, A. K., Rasmussen, C. G., Frohnert, B. I., & Rewers, M. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf095 · Cited by 9
Self-citationEvans‐Molina, C., Dor, Y., Lernmark, Å., Mathieu, C., Millman, J. R., Mirmira, R. G., Pociot, F., REDONDO, M. J., Rich, S. S., Richardson, S. J., et al. (2025) · Diabetes · doi:10.2337/dbi25-0011 · Cited by 9
George S. Eisenbarth: Insulin and Type 1 Diabetes
Pugliese, A., & Skyler, J. S. (2013) · Diabetes Care · doi:10.2337/dc13-0753 · Cited by 11
Self-citationMallone, R., Bismuth, É., Thivolet, C., Benhamou, P., Hoffmeister, N., Collet, F., Nicolino, M. P., Reynaud, R., Beltrand, J., Beltrand, J., et al. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.06.003 · Cited by 11
Buryk, M. A., Dosch, H. ‐., Libman, I. M., Arena, V. C., Huang, Y., Cheung, R. K., Trucco, M., Pietropaolo, M., & BECKER, D. J. (2014) · Diabetes Care · doi:10.2337/dc14-1861 · Cited by 8
Lindbladh, I., Svärd, A. A., & Lernmark, Å. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00041-5 · Cited by 8
Clinical Features and HLA Genetics Differ in Children at Type 1 Diabetes Onset by Hispanic Ethnicity
Karakus, K. E., Fleury, T., Baschal, E. E., McDaniel, K. A., Choi, H., Armstrong, T., Yu, L., Simmons, K. M., & Michels, A. W. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae608 · Cited by 7
Self-citationZhang, M., Wang, X., Wang, R., Shu, J., Zhi, X., Gu, C., Pu, L., Cai, C., Yang, W. Y. L., & Lv, L. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24164 · Cited by 5
Microbiota derived factors as drivers of type 1 diabetes
Tillett, B. J., & Hamilton‐Williams, E. E. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.008 · Cited by 5
Therapeutic Targeting of B Cells and T Cells in Autoimmune Diabetes
Chatenoud, L. (2013) · Diabetes · doi:10.2337/db13-0684 · Cited by 4
Vera, F., Jofré, P., Rodríguez, D., Lagos, R., Quiroga, T., Grassi, B. A., & Felipe Pollak, C. (2021) · Revista médica de Chile · doi:10.4067/s0034-98872021000300330 · Cited by 5
Prediction of Autoimmune Disease
Eisenbarth, G. S., Barker, J. M., & Gianani, R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00078-2 · Cited by 5
Self-citationType 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression
Triolo, T. M., Sosenko, J. M., Cuthbertson, D. D., Oram, R. A., Parikh, H. M., Steck, A. K., Sims, E. K., Jacobsen, L. M., Nathan, B. M., Templeman, E. L., et al. (2025) · Diabetes · doi:10.2337/db25-0711 · Cited by 4
Self-citationPrevalence of markers of beta cell autoimmunity and thyroid disease in children with coeliac disease
Légeret, C., Kutz, A., Jessica, B., Mundwiler, E., Köhler, H., & Bernasconi, L. (2023) · BMC Pediatrics · doi:10.1186/s12887-023-04294-6 · Cited by 5
Zhao, Z., Gu, Y., Cheng, J., & Yu, L. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.75515 · Cited by 2
Self-citationSnell‐Bergeon, J. K., Waugh, K., Dong, F., Steck, A. K., Norris, J., & Rewers, M. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13323 · Cited by 2
Leão, I. S., Araújo, D. B., Barone, B., Dantas, J. R., NOLASCO, M., Soares, M. O., Kendler, D. B., Kupfer, R., Zajdenverg, L., & Rodacki, M. (2021) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000370 · Cited by 2
Bizzaro, N., & Tozzoli, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814307-0.00017-7 · Cited by 2
Immunopathogenesis of type 1 diabetes in Western society
Pugliese, A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch29 · Cited by 2
Long, A. E., Caygill, C. H., Gillespie, K. M., Marčiulionytė, D., & Williams, A. J. K. (2020) · Clinical and Experimental Immunology · doi:10.1111/cei.13524 · Cited by 1
Global determinants and preventive intervention strategies in pediatric type 1 diabetes mellitus
Soliman, N. A., Soliman, A. T., Ahmed, S., Alyafei, F., AlHumaidi, N., Hamed, N., Alaaraj, N., Yassin, D. K., & Elawwa, A. (2026) · Journal of Pediatric Endocrinology and Diabetes · doi:10.25259/jped_56_2025 · Cited by 1
REDONDO, M. J., Cuthbertson, D., Gupta, R., Siller, A. F., Devaraj, S., Vehik, K., Ismail, H. M., & Balasubramanyam, A. (2026) · Diabetes Care · doi:10.2337/dc26-0833 · Cited by 1
Bizzaro, N., Harel, M., & Shoenfeld, Y. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-56378-1.00007-1 · Cited by 1
Delli, A. J., & Lernmark, Å. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00041-1 · Cited by 4
Autoanticorpi nel diabete mellito
Falorni, A., & Minarelli, V. (2013) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.1007/s13631-013-0032-0
Fabien, N. (2014) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(14)72599-7 · Cited by 1
Autoanticorpi nel diabete mellito Autoantibodies in diabetes mellitus
Falorni, A., & Minarelli, V. (2013)
The etiology and pathogenesis of atherosclerosis.
Malmros, H. (1976) · PubMed · Cited by 1
Metadata
- Authors
- Yu, L., Boulware, D. C., Beam, C. A., Hutton, J. C., Wenzlau, J. M., Greenbaum, C. J., Bingley, P. J., Krischer, J. P., Sosenko, J. M., Skyler, J. S., Eisenbarth, G. S., Mahon, J. L., & for the Type 1 Diabetes TrialNet Study Group
- Affiliations
- University of Colorado Denver (US)
- University of South Florida (US)
- University of Washington (US)
- University of Bristol (GB)
- University of Miami (US)
- Western University (CA)
- Corresponding author
- Mahon, Jeffrey L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-05-11
- Volume
- 35
- Issue
- 6
- Pages
- 1213-1218
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3357246
- OpenAlex
- W2055463878
- Cited by
- 104
- References
- 24
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 4 · 2022: 6 · 2021: 10 · 2020: 5 · 2019: 9 · 2018: 4 · 2017: 10 · 2016: 6 · 2015: 7 · 2014: 10 · 2013: 12 · 2012: 4
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Explore Bristol Research (submittedVersion)
- Funders
- American Diabetes Association
- Juvenile Diabetes Research Foundation International
- National Institutes of Health (5ul1rr031986-02, HHSN267200800019C, UL1TR001085, UL1TR000130, UL1TR000454, RR025780, DK017047)
- National Institute of Allergy and Infectious Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK-084565, DK017047, U01DK061040, U01DK085461, U01DK085505, P30DK057516, 017047, U01DK085499, UL1-RR-024139, P30 DK 57516, U01DK061055, U01DK061036, U01DK061010, U01DK061058, U01DK061034, U01DK061042, U01DK085463, U01DK085453, UC4DK117009, U01DK061041, U01DK085466, U01DK085509, U01 DK-061016, R01DK032083, P30DK017047)
- National Institute of Child Health and Human Development
- U.S. National Library of Medicine (HHSN267200800019C)
- National Center for Research Resources (UL1RR025008, UL1RR029890, UL1RR024131, M01RR000400, UL1-RR031986, UL1RR025744, UL1RR024153, UL1RR024982, UL1RR025761, KL2RR024977, M01-RR00400, TL1RR024978, UL1RR024975, UL1RR024139, UL1RR025780)
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HHSN267200800019C)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- zinc transporter 8 antibodies, type 1 diabetes, islet cell antibodies, diabetes risk prediction, relatives of patients, insulin autoantibodies, GAD65 antibodies, IA-2 autoantibodies, HLA genotypes, age as risk factor, oral glucose tolerance test, autoantibody detection
- MeSH terms
- Zinc Transporter 8, Adolescent, Adult, Autoantibodies, Child, Child, Preschool, Diabetes Mellitus, Type 1, Family, Female, Genotype, Glucose Tolerance Test, Humans, Infant, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Cohort Studies, Risk Assessment, Cation Transport Proteins, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.